This bill authorizes an emergency appropriation of approximately $19.66 million to the Oklahoma Department of Mental Health and Substance Abuse Services. The funds must come from the Rate Preservation Fund in the State Treasury and are designated specifically for Title XIX services, which are Medicaid-funded mental health and substance abuse programs. The legislation includes an emergency provision, allowing the funding to take effect immediately upon the governor's approval without waiting for the regular budget cycle. This action provides direct financial resources to the state agency responsible for administering mental health and substance abuse services.
HB 1484, known as "Rain's Law," requires Oklahoma public schools to provide annual, research-based instruction on fentanyl abuse prevention and drug poisoning awareness to students in grades 6 through 12. The bill mandates that this instruction cover suicide prevention, fentanyl abuse and addiction prevention, local resource access, and health education about fentanyl use. Schools must incorporate this content into health classes, and the State Department of Education will develop curriculum standards and resources to support implementation. The law also designates a week for "Fentanyl Poisoning Awareness Week" to align with National Red Ribbon Week, with age-appropriate instruction determined by each school district.
HB 3324 creates a statewide health platform to connect Oklahoma's hospitals, emergency medical services (EMS), and public health entities through a unified, cloud-based system. The platform must provide real-time communication tools - including live video consultations, ECG/image sharing, and emergency alerts - for time-sensitive cases like strokes, heart attacks, and mass casualty incidents. It establishes a revolving fund in the state treasury, funded by state/federal appropriations and donations, to implement and maintain this system. The bill takes effect July 1, 2026, and requires all eligible health entities to use the platform for emergency coordination.
HB 3714 appropriates $1,000,000 from Oklahoma's General Revenue Fund for the Barbara Weber ALS Grant Program during the 2026-2027 fiscal year. The funds will support the Oklahoma State Department of Health in administering grants to assist individuals diagnosed with Amyotrophic Lateral Sclerosis (ALS). The bill authorizes the use of these funds to cover program operations but does not establish new eligibility criteria or services. It becomes effective July 1, 2026, and includes an emergency clause for immediate implementation. This is a funding authorization for an existing program, not a new policy.
HB 3699 requires Oklahoma's Medicaid agency (OHCA) to seek federal approval for a supplemental reimbursement rate for physician practices, community health workers, and nonprofits already enrolled in Oklahoma's patient-centered medical home program. This rate specifically supports pediatric care for children from birth to age four, covering wellness visits and funding interdisciplinary staff needed to implement team-based care aligned with Bright Futures screening guidelines (at 9, 18, and 30 months). Providers must verify ongoing participation in evidence-based pediatric practice models through annual documentation. The bill mandates OHCA to periodically review the rate during future Medicaid physician service rate adjustments and takes effect November 1, 2026.
HB 1709 prohibits creditors and debt collectors from reporting debts related to lifesaving and emergency medical care at Oklahoma medical facilities to credit bureaus. It also bans credit bureaus from including such debts on consumer credit reports. This applies specifically to debts for emergency or life-threatening condition treatments at hospitals, nursing facilities, or licensed medical offices in Oklahoma. The law directly affects Oklahoma residents who receive emergency care, preventing these medical debts from negatively impacting their credit scores. The bill takes effect November 1, 2025.
HB 2945, the "Protecting Moms and Babies Act," prohibits manufacturing, distributing, mailing, transporting, prescribing, or providing abortion-inducing drugs in Oklahoma, with specific exceptions for medical treatments like ectopic pregnancy or miscarriage. It allows only private citizens (via "qui tam" lawsuits) to enforce the ban, not state officials, and explicitly prohibits lawsuits against pregnant women seeking abortion or common carriers transporting patients (if unaware of intent). The law defines "abortion-inducing drugs" to include medications like Mifeprex and misoprostol, excluding use for non-abortion medical purposes. Key exceptions permit the drug's use solely to preserve a mother's life, treat ectopic pregnancy, or address miscarriage-related complications.
SB 207 establishes the Oklahoma Rare Disease Advisory Council within the State Department of Health to address the needs of Oklahomans living with rare diseases (defined as conditions affecting fewer than 200,000 people nationally). The Council, composed of 13 diverse members including patients, caregivers, healthcare providers, researchers, and industry representatives, will conduct public hearings, develop policy recommendations, and create emergency care protocols to improve access to specialists, diagnostics, and equitable treatment. The bill also modifies Oklahoma’s newborn screening program to require an educational initiative for treatable genetic disorders, aiming to prevent intellectual disabilities and reduce infant mortality through early intervention. This legislation directly affects rare disease patients, their families, healthcare providers, and state agencies responsible for public health programs in Oklahoma.
HB 2513, titled the "Oklahoma Mental Health Reform Act of 2025," proposed creating a position requiring an individual with specific qualifications to address the Department of Mental Health and Substance Abuse Services' court-ordered consent decree. The bill specified requirements for this appointee and included an emergency provision. It was scheduled to take effect November 1, 2025, but was pocket-vetoed by the Governor on May 30, 2025, with the veto taking effect June 15, 2025, meaning it never became law. The bill directly affected the Department's compliance with its existing legal agreement but was not enacted.
HB 2645 creates a tax credit for qualifying doctors practicing medicine in rural Oklahoma, directly affecting licensed physicians who meet specific residency and education criteria. The credit, capped at $20,000 per year per doctor, applies to taxable income from medical practice in designated rural areas (population under 25,000 and at least 25 miles from larger cities). The bill includes an annual $1 million total credit limit, with adjustments to prevent exceeding this cap. The bill was pocket-vetoed by the governor on June 15, 2025, and never became law.
